Mitigating Fungal Infection Risk in Patients With Hematologic Cancers

Presentations at the 2018 Annual Meeting of the Hematology/Oncology Pharmacy Association discussed the complexity of managing invasive fungal infection in patients with hematologic malignancies, including the use of therapeutic drug monitoring, employing watchful waiting, and the importance of tailoring antifungal prophylaxis to each patient.

Clinical Oncology News